Asim Roy, MD
Sleep Medicine · Dublin, OHNPI 1639159767
Payments from drug & device makers
Across 1,367 payments — averaging $1622.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$903K
- Takeda Pharmaceuticals U.S.A., Inc.$358K
- Inspire Medical Systems, Inc.$283K
- Harmony Biosciences LLC$223K
- Avadel CNS Pharmaceuticals, LLC$165K
- Noctrix Health, Inc.$80K
- plus $206K from 22 others
What the payments were for
- Consulting fees$266,45240%
- Speaking & faculty fees$336,53351%
- Travel & lodging$43,1526%
- Food & beverage$19,4613%
- Education$6520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 683 | $902,980 |
| Takeda Pharmaceuticals U.S.A., Inc. | 71 | $358,317 |
| Inspire Medical Systems, Inc. | 181 | $282,814 |
| Harmony Biosciences LLC | 171 | $222,630 |
| Avadel CNS Pharmaceuticals, LLC | 67 | $164,993 |
| Noctrix Health, Inc. | 15 | $79,673 |
| Fisher & Paykel Healthcare Limited | 2 | $67,650 |
| Alkermes, Inc. | 39 | $60,753 |
| ZOLL Respicardia, Inc. | 21 | $22,172 |
| Eisai Inc. | 29 | $16,222 |
| Lilly USA, LLC | 19 | $16,136 |
| Axsome Therapeutics, Inc. | 33 | $12,150 |
| Irhythm Technologies, Inc. | 1 | $5,000 |
| Zevra Therapeutics Inc | 1 | $3,020 |
| Resmed Corp | 1 | $1,000 |
| Vertex | 2 | $917 |
| Azurity Pharmaceuticals, Inc. | 12 | $240 |
| Respire Medical Holdings LLC | 1 | $193 |
| Itamar Medical Inc | 1 | $118 |
| Regeneron Healthcare Solutions, Inc. | 1 | $96 |
| Arbor Pharmaceuticals, Inc. | 5 | $90 |
| Fisher & Paykel Healthcare Inc | 2 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Vertical Pharmaceuticals, LLC | 2 | $32 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| 3b Medical, Inc. | 1 | $26 |
| Somnomed Inc. | 1 | $24 |
| Medicomp Inc | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,217,394 in reported general payments places this provider in the 95th percentile of 94 sleep medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| WakixPitolisant Hcl | 60 | $873,805 |
| SunosiSolriamfetol Hcl | 32 | $33,436 |
| Modafinil | 44 | $18,315 |
| QuviviqDaridorexant Hcl | 22 | $10,631 |
| DayvigoLemborexant | 13 | $5,698 |
| Atomoxetine Hcl | 18 | $4,146 |
| Armodafinil | 28 | $1,932 |
| Pregabalin | 32 | $702 |
| Trazodone Hcl | 83 | $613 |
| Gabapentin | 51 | $565 |
| Doxepin Hcl | 26 | $534 |
| Zolpidem Tartrate ErZolpidem Tartrate | 21 | $460 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $445 |
| Methadone Hcl | 34 | $420 |
| Eszopiclone | 23 | $282 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $222,630 | $873,80560 claims |
| Axsome Therapeutics, Inc.Sunosi | $12,150 | $33,43632 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $31 | $10,63122 claims |
| Eisai Inc.Dayvigo | $16,222 | $5,69813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 94 sleep medicine providers in Ohio.
Other sleep medicine in Dublin
- Shikha MistryDublin$8K
- Nancy Foldvary-SchaeferCleveland$1.6M
- Shahrokh JavaheriCincinnati$404K
- Louis TartagliaMaumee$314K
- John AndrefskyParma$147K
- Ulysses MagalangColumbus$143K
- Sally IbrahimCleveland$130K
- Anthony SuchoskiCincinnati$89K
- Shayla PullenCincinnati$71K
- Mansoor AhmedWestlake$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.